Sign In
Buy VXRT
$0.519
-0.0111 (-2.09%)
At Close: Jun 23, 2026
Vaxart (VXRT) Catches Eye: Stock Jumps 7.9%
08:59am, Friday, 17'th Jul 2020
Vaxart (VXRT) saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes.
3 Game-Changing Coronavirus Vaccine Stocks That May Make You Rich
08:46am, Friday, 17'th Jul 2020
These three vaccine stocks show no signs of slowing down their breathtaking pace of growth.
Why Vaxart Stock Is Soaring Today
11:51am, Thursday, 16'th Jul 2020
A new study shows that there is a dire need for a vaccine of the kind Vaxart is developing.
Implied Volatility Surging for Vaxart (VXRT) Stock Options
08:43am, Thursday, 16'th Jul 2020
Investors need to pay close attention to Vaxart (VXRT) stock based on the movements in the options market lately.
Norovirus Gastroenteritis Costs an Estimated $10.6 Billion Each Year in the United States
08:00am, Thursday, 16'th Jul 2020
Over 90% of norovirus' total annual cost is due to sporadic spread in the community. Over 90% of norovirus' total annual cost is due to sporadic spread in the community.
These 2 Coronavirus Stocks Could Soar in the Second Half of 2020
10:48am, Wednesday, 15'th Jul 2020
Both Moderna and Vaxart are expecting data readouts that will send the stocks skyrocketing -- if the news is positive.
Why Vaxart Stock Soared 40% Today
06:06pm, Tuesday, 14'th Jul 2020
Investors are growing increasingly bullish on the coronavirus vaccine maker's growth prospects.
Why Vaxart's Stock Is Trading Higher Today
03:25pm, Monday, 13'th Jul 2020
Vaxart Inc (NASDAQ: VXRT) shares are trading higher on Monday after B Riley FBR initiated coverage on the company's stock with a Buy rating and announced a $22 price target.
Vaxart Raises Approximately $90M in Gross Proceeds Through its At-The-Market-Facility
01:34pm, Monday, 13'th Jul 2020
RA Capital Management to own approximately 9.99% of the Company’s outstanding common stock RA Capital Management to own approximately 9.99% of the Company’s outstanding common stock
Everything You Need to Know About Vaxart and Its Potential Coronavirus Vaccine
08:13am, Saturday, 11'th Jul 2020
As a small and scrappy competitor in the COVID-19 vaccine race, Vaxart is a lucrative opportunity for investors of all stripes.
Coronavirus Vaccine Race: Moderna or Vaxart?
10:12am, Thursday, 09'th Jul 2020
Both companies are developing new types of vaccines. The risk is high -- but so is potential for share performance.
Better Coronavirus Stock: Altimmune vs. Vaxart
06:40am, Wednesday, 08'th Jul 2020
Both of these small-cap vaccine stocks are up big in 2020.
Better Coronavirus Stock: VBI Vaccines or Vaxart?
06:52am, Tuesday, 07'th Jul 2020
There's more to these small biotechs than just their coronavirus vaccine programs.
Vaxart's Technology Could Be A COVID-19 Game Changer
05:34pm, Monday, 06'th Jul 2020
Vaxart's Technology Could Be A COVID-19 Game Changer
Vaxart: A Speculative Buy For Its Oral COVID-19 Vaccine
02:08pm, Monday, 06'th Jul 2020
Vaxart is a small cap, clinical-stage biotech company that develops oral tablet vaccines for infectious diseases.
